Related Experiment Video
Updated: May 10, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Helminth infection and type 1 diabetes
1Department of Pathology, University of Cambridge, Tennis Court Rd, Cambridge CB2 1QP, UK.
The Review of Diabetic Studies : RDS
|June 28, 2013
Summary
Environmental factors, like infections, increasingly contribute to type 1 diabetes (T1D). Helminths, or parasitic worms, show potential in modulating T1D and autoimmune diseases, though clinical application faces challenges.
Area of Science:
- Immunology and Environmental Health
- Autoimmune Disease Pathogenesis
Background:
- Rising type 1 diabetes (T1D) and autoimmune disease incidence in industrialized nations suggests environmental influences beyond genetics.
- The hygiene hypothesis posits that reduced exposure to pathogens due to sanitation has impaired immune system regulation.
- Helminths possess sophisticated mechanisms to modulate host immunity, potentially offering protective effects against inflammation and autoimmunity.
Purpose of the Study:
- To review the capacity of helminths to influence the development and progression of type 1 diabetes (T1D).
- To identify challenges associated with translating helminth-derived therapies for clinical application in T1D treatment.
Main Methods:
- Review of epidemiological studies and animal experimental data on environmental factors and autoimmune diseases.
- Analysis of helminthic immune modulation strategies and their effects on innate and adaptive immunity.
- Examination of in vitro and in vivo studies on helminth-derived antigens and molecules for therapeutic potential in T1D.
Main Results:
- Helminth infections induce significant immune system alterations that can be protective in inflammatory and autoimmune conditions.
- Helminth-derived molecules are being investigated for their therapeutic effects on inflammatory and autoimmune diseases, including T1D.
- The immunomodulatory properties of helminths offer a novel therapeutic avenue for T1D.
Conclusions:
- Helminths demonstrate a capacity to modulate the onset and progression of type 1 diabetes (T1D).
- Significant challenges remain in the clinical translation of helminth-based therapies for T1D due to safety and efficacy considerations.
More Related Videos
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.